APO Research
Talk to an analyst

APO RESEARCH · REPORT

Testosterone Hormone Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Testosterone Hormone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchTestosterone Hormone Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Testosterone Hormone Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Testosterone Hormone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Testosterone Hormone Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Testosterone Hormone Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Testosterone Hormone Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Testosterone Hormone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Testosterone Hormone Drug include Teva, Novartis, Eli lilly, Pfizer, Bayer, AbbVie, Viatris, Upsher-Smith and Kyowa Kirin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Testosterone Hormone Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Testosterone Hormone Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Testosterone Hormone Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Testosterone Hormone Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Testosterone Hormone Drug Segment by Company

Teva

Novartis

Eli lilly

Pfizer

Bayer

AbbVie

Viatris

Upsher-Smith

Kyowa Kirin

Ferring Pharmaceuticals

Endo International

Actavis (Allergan)

Acerus Pharmaceuticals

Testosterone Hormone Drug Segment by Type

Gels

Patches

Injections

Testosterone Hormone Drug Segment by Application

Hospitals

Clinics

Others

Testosterone Hormone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Testosterone Hormone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Testosterone Hormone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Testosterone Hormone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Testosterone Hormone Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Testosterone Hormone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Testosterone Hormone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Testosterone Hormone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Testosterone Hormone Drug Industry Trends Table 2. Testosterone Hormone Drug Industry Drivers Table 3. Testosterone Hormone Drug Industry Opportunities and Challenges Table 4. Testosterone Hormone Drug Industry Restraints Table 5. Global Testosterone Hormone Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Testosterone Hormone Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Testosterone Hormone Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Testosterone Hormone Drug Sales Market Share by Manufacturers Table 9. Global Testosterone Hormone Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Testosterone Hormone Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Testosterone Hormone Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Testosterone Hormone Drug Manufacturers, Product Type & Application Table 13. Global Testosterone Hormone Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Testosterone Hormone Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gels Table 17. Major Manufacturers of Patches Table 18. Major Manufacturers of Injections Table 19. Global Testosterone Hormone Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Testosterone Hormone Drug Sales by Type (2021-2026) & (K Units) Table 21. Global Testosterone Hormone Drug Sales by Type (2027-2032) & (K Units) Table 22. Global Testosterone Hormone Drug Sales Market Share by Type (2021-2026) Table 23. Global Testosterone Hormone Drug Sales Market Share by Type (2027-2032) Table 24. Global Testosterone Hormone Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Testosterone Hormone Drug Revenue by Type (2021-2026) & (K Units) Table 26. Global Testosterone Hormone Drug Revenue by Type (2027-2032) & (K Units) Table 27. Global Testosterone Hormone Drug Revenue Market Share by Type (2021-2026) Table 28. Global Testosterone Hormone Drug Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Testosterone Hormone Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Testosterone Hormone Drug Sales by Application (2021-2026) & (K Units) Table 34. Global Testosterone Hormone Drug Sales by Application (2027-2032) & (K Units) Table 35. Global Testosterone Hormone Drug Sales Market Share by Application (2021-2026) Table 36. Global Testosterone Hormone Drug Sales Market Share by Application (2027-2032) Table 37. Global Testosterone Hormone Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Testosterone Hormone Drug Revenue by Application (2021-2026) & (K Units) Table 39. Global Testosterone Hormone Drug Revenue by Application (2027-2032) & (K Units) Table 40. Global Testosterone Hormone Drug Revenue Market Share by Application (2021-2026) Table 41. Global Testosterone Hormone Drug Revenue Market Share by Application (2027-2032) Table 42. Global Testosterone Hormone Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Testosterone Hormone Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Testosterone Hormone Drug Sales Market Share by Region (2021-2026) Table 45. Global Testosterone Hormone Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Testosterone Hormone Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 49. North America Testosterone Hormone Drug Sales by Country (2027-2032) & (K Units) Table 50. Europe Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 52. Europe Testosterone Hormone Drug Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Testosterone Hormone Drug Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Testosterone Hormone Drug Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Testosterone Hormone Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Testosterone Hormone Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Testosterone Hormone Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Testosterone Hormone Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Testosterone Hormone Drug Revenue Market Share by Region (2021-2026) Table 63. Global Testosterone Hormone Drug Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Testosterone Hormone Drug Product Portfolio Table 68. Teva Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Novartis Testosterone Hormone Drug Product Portfolio Table 73. Novartis Recent Development Table 74. Eli lilly Company Information Table 75. Eli lilly Business Overview Table 76. Eli lilly Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Eli lilly Testosterone Hormone Drug Product Portfolio Table 78. Eli lilly Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Testosterone Hormone Drug Product Portfolio Table 83. Pfizer Recent Development Table 84. Bayer Company Information Table 85. Bayer Business Overview Table 86. Bayer Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bayer Testosterone Hormone Drug Product Portfolio Table 88. Bayer Recent Development Table 89. AbbVie Company Information Table 90. AbbVie Business Overview Table 91. AbbVie Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. AbbVie Testosterone Hormone Drug Product Portfolio Table 93. AbbVie Recent Development Table 94. Viatris Company Information Table 95. Viatris Business Overview Table 96. Viatris Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Viatris Testosterone Hormone Drug Product Portfolio Table 98. Viatris Recent Development Table 99. Upsher-Smith Company Information Table 100. Upsher-Smith Business Overview Table 101. Upsher-Smith Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Upsher-Smith Testosterone Hormone Drug Product Portfolio Table 103. Upsher-Smith Recent Development Table 104. Kyowa Kirin Company Information Table 105. Kyowa Kirin Business Overview Table 106. Kyowa Kirin Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Kyowa Kirin Testosterone Hormone Drug Product Portfolio Table 108. Kyowa Kirin Recent Development Table 109. Ferring Pharmaceuticals Company Information Table 110. Ferring Pharmaceuticals Business Overview Table 111. Ferring Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Ferring Pharmaceuticals Testosterone Hormone Drug Product Portfolio Table 113. Ferring Pharmaceuticals Recent Development Table 114. Endo International Company Information Table 115. Endo International Business Overview Table 116. Endo International Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Endo International Testosterone Hormone Drug Product Portfolio Table 118. Endo International Recent Development Table 119. Actavis (Allergan) Company Information Table 120. Actavis (Allergan) Business Overview Table 121. Actavis (Allergan) Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Actavis (Allergan) Testosterone Hormone Drug Product Portfolio Table 123. Actavis (Allergan) Recent Development Table 124. Acerus Pharmaceuticals Company Information Table 125. Acerus Pharmaceuticals Business Overview Table 126. Acerus Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Acerus Pharmaceuticals Testosterone Hormone Drug Product Portfolio Table 128. Acerus Pharmaceuticals Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Testosterone Hormone Drug Distributors List Table 132. Testosterone Hormone Drug Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Testosterone Hormone Drug Product Image Figure 2. Global Testosterone Hormone Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Testosterone Hormone Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Testosterone Hormone Drug Sales (2021-2032) & (K Units) Figure 5. Global Testosterone Hormone Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Testosterone Hormone Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gels Image Figure 9. Patches Image Figure 10. Injections Image Figure 11. Global Testosterone Hormone Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Testosterone Hormone Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Testosterone Hormone Drug Sales Market Share by Type (2021-2032) Figure 14. Global Testosterone Hormone Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Testosterone Hormone Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Testosterone Hormone Drug Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Testosterone Hormone Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Testosterone Hormone Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Testosterone Hormone Drug Sales Market Share by Application (2021-2032) Figure 23. Global Testosterone Hormone Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Testosterone Hormone Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Testosterone Hormone Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Testosterone Hormone Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Testosterone Hormone Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Testosterone Hormone Drug Sales Market Share by Country (2021-2032) Figure 40. China Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Testosterone Hormone Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Testosterone Hormone Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Testosterone Hormone Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Testosterone Hormone Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Testosterone Hormone Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Testosterone Hormone Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Testosterone Hormone Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Testosterone Hormone Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Testosterone Hormone Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Testosterone Hormone Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gels
  • Patches
  • Injections
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Teva
  • Novartis
  • Eli lilly
  • Pfizer
  • Bayer
  • AbbVie
  • Viatris
  • Upsher-Smith
  • Kyowa Kirin
  • Ferring Pharmaceuticals
  • Endo International
  • Actavis (Allergan)
  • Acerus Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Testosterone Hormone Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Testosterone Hormone Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Testosterone Hormone Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Testosterone Hormone Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Testosterone Hormone Drug Market Dynamics
  1. 2.1 Testosterone Hormone Drug Industry Trends
  2. 2.2 Testosterone Hormone Drug Industry Drivers
  3. 2.3 Testosterone Hormone Drug Industry Opportunities and Challenges
  4. 2.4 Testosterone Hormone Drug Industry Restraints
3 Testosterone Hormone Drug Market by Manufacturers
  1. 3.1 Global Testosterone Hormone Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Testosterone Hormone Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Testosterone Hormone Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Testosterone Hormone Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Testosterone Hormone Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Testosterone Hormone Drug Manufacturers, Product Type & Application
  7. 3.7 Global Testosterone Hormone Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Testosterone Hormone Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Testosterone Hormone Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Testosterone Hormone Drug Tier 1, Tier 2, and Tier 3
4 Testosterone Hormone Drug Market by Type
  1. 4.1 Testosterone Hormone Drug Type Introduction
  2. 4.1.1 Gels
  3. 4.1.2 Patches
  4. 4.1.3 Injections
  5. 4.2 Global Testosterone Hormone Drug Sales by Type
  6. 4.2.1 Global Testosterone Hormone Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Testosterone Hormone Drug Sales by Type (2021-2032)
  8. 4.2.3 Global Testosterone Hormone Drug Sales Market Share by Type (2021-2032)
  9. 4.3 Global Testosterone Hormone Drug Revenue by Type
  10. 4.3.1 Global Testosterone Hormone Drug Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Testosterone Hormone Drug Revenue by Type (2021-2032)
  12. 4.3.3 Global Testosterone Hormone Drug Revenue Market Share by Type (2021-2032)
5 Testosterone Hormone Drug Market by Application
  1. 5.1 Testosterone Hormone Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Testosterone Hormone Drug Sales by Application
  6. 5.2.1 Global Testosterone Hormone Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Testosterone Hormone Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Testosterone Hormone Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Testosterone Hormone Drug Revenue by Application
  10. 5.3.1 Global Testosterone Hormone Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Testosterone Hormone Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Testosterone Hormone Drug Revenue Market Share by Application (2021-2032)
6 Global Testosterone Hormone Drug Sales by Region
  1. 6.1 Global Testosterone Hormone Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Testosterone Hormone Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Testosterone Hormone Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Testosterone Hormone Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Testosterone Hormone Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Testosterone Hormone Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Testosterone Hormone Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Testosterone Hormone Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Testosterone Hormone Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Testosterone Hormone Drug Revenue by Region
  1. 7.1 Global Testosterone Hormone Drug Revenue by Region
  2. 7.1.1 Global Testosterone Hormone Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Testosterone Hormone Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Testosterone Hormone Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Testosterone Hormone Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Testosterone Hormone Drug Revenue (2021-2032)
  8. 7.2.2 North America Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Testosterone Hormone Drug Revenue (2021-2032)
  11. 7.3.2 Europe Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Testosterone Hormone Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Testosterone Hormone Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Testosterone Hormone Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Testosterone Hormone Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Testosterone Hormone Drug Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Eli lilly
  14. 8.3.1 Eli lilly Company Information
  15. 8.3.2 Eli lilly Business Overview
  16. 8.3.3 Eli lilly Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli lilly Testosterone Hormone Drug Product Portfolio
  18. 8.3.5 Eli lilly Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Testosterone Hormone Drug Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Testosterone Hormone Drug Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Testosterone Hormone Drug Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Testosterone Hormone Drug Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 Upsher-Smith
  44. 8.8.1 Upsher-Smith Company Information
  45. 8.8.2 Upsher-Smith Business Overview
  46. 8.8.3 Upsher-Smith Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Upsher-Smith Testosterone Hormone Drug Product Portfolio
  48. 8.8.5 Upsher-Smith Recent Developments
  49. 8.9 Kyowa Kirin
  50. 8.9.1 Kyowa Kirin Company Information
  51. 8.9.2 Kyowa Kirin Business Overview
  52. 8.9.3 Kyowa Kirin Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kyowa Kirin Testosterone Hormone Drug Product Portfolio
  54. 8.9.5 Kyowa Kirin Recent Developments
  55. 8.10 Ferring Pharmaceuticals
  56. 8.10.1 Ferring Pharmaceuticals Company Information
  57. 8.10.2 Ferring Pharmaceuticals Business Overview
  58. 8.10.3 Ferring Pharmaceuticals Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ferring Pharmaceuticals Testosterone Hormone Drug Product Portfolio
  60. 8.10.5 Ferring Pharmaceuticals Recent Developments
  61. 8.11 Endo International
  62. 8.11.1 Endo International Company Information
  63. 8.11.2 Endo International Business Overview
  64. 8.11.3 Endo International Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Endo International Testosterone Hormone Drug Product Portfolio
  66. 8.11.5 Endo International Recent Developments
  67. 8.12 Actavis (Allergan)
  68. 8.12.1 Actavis (Allergan) Company Information
  69. 8.12.2 Actavis (Allergan) Business Overview
  70. 8.12.3 Actavis (Allergan) Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Actavis (Allergan) Testosterone Hormone Drug Product Portfolio
  72. 8.12.5 Actavis (Allergan) Recent Developments
  73. 8.13 Acerus Pharmaceuticals
  74. 8.13.1 Acerus Pharmaceuticals Company Information
  75. 8.13.2 Acerus Pharmaceuticals Business Overview
  76. 8.13.3 Acerus Pharmaceuticals Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Acerus Pharmaceuticals Testosterone Hormone Drug Product Portfolio
  78. 8.13.5 Acerus Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Testosterone Hormone Drug Value Chain Analysis
  2. 9.1.1 Testosterone Hormone Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Testosterone Hormone Drug Production Mode & Process
  6. 9.2 Testosterone Hormone Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Testosterone Hormone Drug Distributors
  9. 9.2.3 Testosterone Hormone Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst